Singapore

22 NOVEMBER 2018 - English translation for the Chinese news article can be found on https://www.hyphensgroup.com/interview-with-lianhe-zaobao/

Hyphens Pharma International Ltd. is a leading specialty pharmaceutical and consumer healthcare group in Southeast Asia. It markets and distributes specialty pharmaceutical products, develops proprietary dermatological and health supplement brands, and operates a medical hypermart and digital pharmacy platform. The company is headquartered in Singapore and was founded in 1988.

联合早报 - 修读课程突破思维业者自我创新“药”走向国际

22 MARCH 2019 - Dr Koh lauded the company's partnership with public agencies like the Agency for Science, Technology and Research (A*Star) since 2014: "Through its strong partnerships with public-sector agencies, Hyphens has been able to develop new products that not only enabled it to sustain its growth and move into new markets, but also help improve the health and lives of people."

The New Paper - Innovation key to help companies expand: Koh Poh Koon

2019年3月22日 - "本地公司须要继续创新，以建立它们在环球市场的竞争优势。"

联合早报 - 凯帆药剂新总部开幕 许宝琨：本地公司须持续创新建立竞争优势

10 MAY 2019 - Investor-One's take on 5 stocks listed on the Singapore Exchange Catalist board.

RHB’s 20 Jewels 2019 Edition: Investor-One’s Analysis Of 5 Catalist Stocks

16 MAY 2019 - "The scalability of Hyphens's business rides on the two megatrends of this region:
(1) Fast-growing economies, rapid urbanisation and domestic consumption based on huge populations; and (2) The increasing numbers of consumers with high disposable income and their consumption of not only specialty pharmaceuticals but also consumer healthcare products from skincare products to nutritional supplements."

Investor-One - Hyphens Pharma: A scalable business that rides on regional megatrends

07 MAY 2019 - "RHB Securities Singapore launched its 9th edition of Top Singapore Small Cap Companies book, highlighting 20 undiscovered jewels that have the potential to thrive in coming years. This essential Small Cap investing handbook aspires to create value for investors by providing detailed analysis and recommendations for hidden gems within SGX-listed small-cap companies."

RHB's 2019 Top Singapore Small Cap Companies (9th Edition)

22 MARCH 2019 - "The five-year commercialisation deal covers development of products targeting eczema, acne, pigmentary disorders."

The Business Times - Hyphens inks MOU with A*Star's A*ccelerate

22 MARCH 2019 - "Innovate for global competitive edge, says Koh Poh Koon."

The Straits Times – Innovate for global competitive edge, says Koh Poh Koon

21 MARCH 2019 - "New products to help those suffering from common skin problems like eczema could be available as early as next year. That's the focus of a collaboration between A*STAR's commercialisation arm, A*ccelerate, and Hyphens Pharma. Brandon Tanoto reports."

Channel News Asia - New products in the works for common skin problems | Video

08 DEC 2019 - "In this monthly series, The Sunday Times and Singapore Exchange's research team interview company bosses to help investors get a better look at a firm's operations, one that goes beyond the financials. We speak to Hyphens Pharma chief operating officer Yann Marche."

The Straits Times - Aiming to be Asia's No. 1 skin-health firm

16 MAY 2019 - "Hyphens Pharma's CEO Lim See Wah tells us about Hyphens's presence and growth prospects in the region."

Hyphens Pharma's CEO Lim See Wah tells us about Hyphens's presence and growth prospects in the region

Financial blogger, James, shares his thoughts on our strong first quarter results. What are the 5 things he likes about Hyphens Pharma?

Hyphens Pharma: 5 things I like about the company

Financial blogger, Brian, wrote on Hyphens Pharma's  businesses and first quarter financial results. He also gave his take to these questions: Is the growth sustainable post-COVID? How much is the valuation? What are the potential risks that investors might want to watch out for? and more.

Hyphens Pharma International Ltd (SGX: 1J5) - Uncovering Healthcare Gems

Royston, financial blogger of New Academy of Finance, provided his detailed analysis into the Group's financial performance, growth potential, valuation and key risks. Read on to find out if Hyphens Pharma is undervalued.

Hyphens Pharma: Is this pharma company undervalued?

"It is using technology to stay in touch with medical professionals and connect with consumers; it is even exploring telemedicine." - The Business Times. Read more 👇

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hyphens Pharma (HYP SP)

Hyphens Pharma revs up digital push amid Covid-19

Hyphens Pharma: Is this pharma company undervalued?

Hyphens Pharma International Ltd (SGX: 1J5) - Uncovering Healthcare Gems

Hyphens Pharma: 5 things I like about the company

The Straits Times - Aiming to be Asia's No. 1 skin-health firm

Investor-One - Hyphens Pharma: A scalable business that rides on regional megatrends

Hyphens Pharma's CEO Lim See Wah tells us about Hyphens's presence and growth prospects in the region

RHB’s 20 Jewels 2019 Edition: Investor-One’s Analysis Of 5 Catalist Stocks

RHB's 2019 Top Singapore Small Cap Companies (9th Edition)

联合早报 - 凯帆药剂新总部开幕许宝琨：本地公司须持续创新建立竞争优势

The Business Times - Hyphens inks MOU with AStar's Accelerate

The Straits Times – Innovate for global competitive edge, says Koh Poh Koon

The New Paper - Innovation key to help companies expand: Koh Poh Koon

Channel News Asia - New products in the works for common skin problems | Video

联合早报 - 修读课程突破思维业者自我创新“药”走向国际

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Hyphens Pharma revs up digital push amid Covid-19

Hyphens Pharma: Is this pharma company undervalued?

Hyphens Pharma International Ltd (SGX: 1J5) - Uncovering Healthcare Gems

Hyphens Pharma: 5 things I like about the company

The Straits Times - Aiming to be Asia's No. 1 skin-health firm

Investor-One - Hyphens Pharma: A scalable business that rides on regional megatrends

Hyphens Pharma's CEO Lim See Wah tells us about Hyphens's presence and growth prospects in the region

RHB’s 20 Jewels 2019 Edition: Investor-One’s Analysis Of 5 Catalist Stocks

RHB's 2019 Top Singapore Small Cap Companies (9th Edition)

联合早报 - 凯帆药剂新总部开幕 许宝琨：本地公司须持续创新建立竞争优势

The Business Times - Hyphens inks MOU with A*Star's A*ccelerate

The Straits Times – Innovate for global competitive edge, says Koh Poh Koon

The New Paper - Innovation key to help companies expand: Koh Poh Koon

Channel News Asia - New products in the works for common skin problems | Video

联合早报 - 修读课程突破思维业者自我创新“药”走向国际

联合早报 - 凯帆药剂新总部开幕许宝琨：本地公司须持续创新建立竞争优势

The Business Times - Hyphens inks MOU with AStar's Accelerate